Lipocine director Spyros Papapetropoulos resigns; R. Dana Ono appointed Chairman

Lipocine Inc.

Spyros Papapetropoulos resigned from Lipocine Board effective April 16, 2026, citing competing commitments and differing views on strategic direction.
R. Dana Ono appointed Chairman and Lead Independent Director on April 20, 2026, replacing Papapetropoulos.
Papapetropoulos had served on the Board since 2022 and was Chairman prior to resignation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.